📞 Webinar: Recurrent Pituitary Adenomas – What are the options?

 

Presented by

Dr. Magge, Assistant Professor of Neurology at Weill Cornell Medical College and an Assistant Attending Neurologist at New York-Presbyterian Hospital.

Dr. Ranakrishna, Chief of Neurological Surgery at NewYork-Presbyterian Brooklyn Methodist Hospital, Associate Professor of Neurological Surgery at Avina and Willis Murphy at Weill Cornell Medicine

Click here to attend.

Date: Tuesday, October 13, 2020

Time: 10:00 AM Eastern Daylight Time

Learning objectives:

–          the basic characteristics of the different types of pituitary adenomas

–          the potential predictors of recurrence and aggressiveness in pituitary adenomas

–          the surgical and radiotherapy options for recurrent pituitary adenomas

–          the potential medical interventions, including chemotherapy, for recurrent pituitary adenomas

📞 Webinar: Expect more from pituitary surgery: difference-makers for post-operative outcomes

 Presented by

Ahmad Sedaghat, MD, PhD – Associate Professor and Director of the Division of Rhinology, Allergy and Anterior Skull Base Surgery in the Department of Otolaryngology – Head and Neck Surgery at the University of Cincinnati College of Medicine and UC Health.

Norberto Andaluz, MD, MBA, FACS – Professor of Neurosurgery and Otolaryngology/Head and Neck Surgery – Director, Division of Skull Base Surgery University of Cincinnati College of Medicine and University of Cincinnati Gardner Neuroscience Institute – UC Health

 

Click here to attend

Date: Wednesday, Sept 23, 2020

Time: 3:00 PM  Eastern Daylight Time

Learning objectives:

1.  To understand the surgical steps of endoscopic pituitary surgery
2.  To understand how the surgical steps of endoscopic pituitary surgery translate to post-operative outcomes
3.  To understand surgical factors that can modify post-operative outcomes after endoscopic pituitary surgery
4.  To understand post-operative care that can modify post-operative outcomes after endoscopic pituitary surgery

📞 Webinar: The Current “State-of-the-Art” in the Treatment of Pituitary Disease.

Presented by

Georgios A. Zenonos, MDAssistant Professor of Neurological Surgery
Associate Director, Center for Skull Base Surgery
University of Pittsburgh Medical Center200 Lothrop Street, Pittsburgh PA, 15217
Presbyterian Hospital, Suite B400

No Registration is Required.  It will be webcast by Microsoft Teams.

Click here to attend.

Date: Friday, July 17, 2020

Time: 10:00 AM Pacific Daylight Time, 1:00 PM Eastern Daylight Time

📞 Webinar: What every Patient needs to know about Recent Advancements in Pituitary Surgery

Presented by Georgios A. Zenonos, MD

Assistant Professor of Neurological Surgery
Associate Director, Center for Skull Base Surgery
University of Pittsburgh Medical Center

200 Lothrop Street, Pittsburgh PA, 15217
Presbyterian Hospital, Suite B400

Register Now!

After registering you will receive a confirmation email containing information about joining the Webinar.

Date: Wednesday, July 1, 2020

Time: 3:00 PM Pacific Daylight Time, 6:00 PM Eastern Daylight Time

📞 Webinar: Pituitary Surgery During the COVID-19 Pandemic

 

Presented by

Jamie J. Van Gompel, M.D., B.S., Professor in Neurosurgery and Otolaryngology specializing in endoscopic/open skull base focusing on Pituitary tumors as well as Epilepsy at the Mayo Clinic in Rochester, Minnesota, USAand

Garret W. Choby, M.D., a fellowship-trained rhinologist and endoscopic skull base surgeon practicing at the Mayo Clinic.

Objectives:

–          Understand the additional considerations that are key to performing endonasal surgery during the COVID pandemic
–          Identify the practice changes that are allowing pituitary surgery to proceed safely
–          Characterize the nasal cavity and nasopharynx as a reservoir for the coronavirus
–          Identify the risk of undergoing pituitary surgery during the Covid -19 pandemic
After registering you will receive a confirmation email containing information about joining the Webinar.Date: Monday, May 11, 2020

Time: 4:00 PM Pacific Daylight Time  – 5:15 PM Pacific Daylight Time

📞 Webinar: The Implications of COVID-19 on Patients with Endocrine Disorders

 

Presented by

Nelson M. Oyesiku, MD, PhD, FACS
Professor of Neurosurgery and Medicine
Vice-Chairman, Neurosurgery Residency Program Director
Emory University School of Medicine

Register Now!

After registering you will receive a confirmation email containing information about joining the Webinar.

 

Date: Sunday, May 10, 2020

Time: 11:00 AM Pacific Daylight Time to 12:15 PM Pacific Daylight Time/ 2:00 PM – 3:15 PM Eastern Daylight Time

📞Dr. Theodore Friedman will host an important Webinar on Coronavirus Information for Endocrine Patients

Dr. Theodore Friedman will host an important webinar on Coronavirus Information for Endocrine Patients

Many patients have asked Dr. Friedman what do during the Coronavirus Pandemic. He will give candid answers from his view as an Endocrinologist. He will also talk about new telehealth opportunities for his patients.

Sunday • April 5 • 6 PM PST
Click here on start your meeting or
https://axisconciergemeetings.webex.com/axisconciergemeetings/j.php?MTID=m505da5a10afe3aeea456e162414c17b9

OR
Join by phone: (855) 797-9485

Meeting Number (Access Code): 807 657 124
Your phone/computer will be muted on entry.
Slides will be available on the day of the talk here
There will be plenty of time for questions using the chat button.

Meeting Password: hormones
For more information, email us at mail@goodhormonehealth.com

📞Webinar: Perioperative Care for the Pituitary Patient: Optimizing the Surgical Experience

Presented by

Varun Kshettry, MD
Director, Advanced Endoscopic & Microscopic Neurosurgery
Cleveland Clinic Lerner College of Medicine

Register Now

After registering you will receive a confirmation email with details about joining the webinar.

 

Date: Tuesday, February 18, 2020
Time: 10:00 AM – 11:00 AM Pacific Standard Time, 1:00 PM – 2:00 PM Eastern Standard Time

Learning Objectives:

Discuss patient expectations for pituitary surgery and recovery
Discuss best practices to minimize risk of complications
What questions to ask your medical providers

Presenter Bio

Dr. Varun R. Kshettry, a neurosurgeon specializing in skull base and pituitary disorders at the Cleveland Clinic. He is also the director of the Advanced Endoscopic & Microscopic Neurosurgery Laboratory. He is an assistant professor of neurosurgery at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Dr. Kshettry received his BA in philosophy at the University of Pennsylvania. He earned his medical degree from Northwestern University. He completed his residency training at the Cleveland Clinic, during which he performed a research fellowship in skull base & microsurgical anatomy at Ohio State University. He then performed a clinical fellowship in minimally invasive cranial base & pituitary surgery at Thomas Jefferson University under Dr. James Evans. Dr. Kshettry has authored more than 100 peer-reviewed publications and book chapters and is an editor for a book entitled Endoscopic and Keyhole Cranial Base Surgery. He serves as an editor or reviewer for multiple neurosurgical journals. He serves on the Value-Based Healthcare Committee for the North American Skull Base Society. He serves as faculty director for the Cleveland Clinic Pituitary Tumor Board and is an investigator in several multi-center pituitary clinical trials. Dr. Kshettry collaborates closely with pituitary endocrinologists, neuro-ophthalmologists, otolaryngologists, pituitary pathologists, and radiation oncologists for multi-disciplinary care for patients with pituitary diseases.

📞 Webinar: Management of Recurrent Pituitary Tumors

Wed, Jan 8, 2020, from 4:00 PM – 5:00 PM EST

Presented by Paul Gardner, MD Associate Professor of Neurological Surgery Neurosurgical Director, Center for Cranial Base Surgery Executive Vice Chairman for Surgical Services University Pittsburgh Medical Center (UPMC)

Learning Objectives: Upon completion of this webinar, participants should be able to: Recognize the role for surgery in treating recurrent adenomas Understand the risk and role of radiosurgery for treatment of recurrent Identify treatment indications for recurrent adenomas.

Presenter Bio Paul A. Gardner, MD, is an Associate Professor in the Department of Neurological Surgery at the University of Pittsburgh School of Medicine and Neurosurgical Director of the Center for Cranial Base Surgery as well as Executive Vice Chairman for Surgical Services for the Department of Neurological Surgery at the University of Pittsburgh Medical Center (UPMC).

Dr. Gardner joined the faculty of the Department of Neurological Surgery at the University of Pittsburgh School of Medicine in 2008 after completing his residency and fellowship training at the University of Pittsburgh. He completed his undergraduate studies at Florida State University, majoring in biochemistry, and received his Medical Degree from the University of Pittsburgh School of Medicine.

Dr. Gardner completed a two-year fellowship in endoscopic endonasal pituitary and endoscopic and open skull base surgery at the University of Pittsburgh Medical Center. His research has focused on evaluating patient outcomes following these surgeries and more recently on molecular phenotyping of rare tumors. He is recognized internationally as a leader in the field of endoscopic endonasal surgery, a minimally invasive surgical approach to the skull base. His other surgical interests include pituitary tumors, open cranial base surgery, and vascular surgery.

Register here

📞 Webinar: Experimental Treatments for Aggressive Pituitary Tumors

Presented by

Andrew Lin, MD
Neuro-Oncologist & Neurologist
Memorial Sloak Kettering Cancer Center

After registering you will receive a confirmation email with details about joining the webinar.

Contact us at webinar@pituitary.org with any questions or suggestions.

Date: September 18, 2019
Time: 10:00 AM – 11:00 AM. Pacific Daylight Time, 1:00 PM – 2:00 PM Eastern Daylight Time

Learning Objectives:

During the conversation I will be:
1) Defining aggressive pituitary tumors.
2) Reviewing the current treatment options for aggressive pituitary tumors.
3) Discussing experimental treatment options including a phase II trial investigating the activity of the immunotherapies nivolumab and ipilimumab.

Presenter Biography:

I am a neuro-oncologist at Memorial Sloan Kettering Cancer Center (MSK) and a member of the Multidisciplinary Pituitary & Skull Base Tumor Center. In collaboration with my colleagues in endocrine, neurosurgery, and radiation oncology, I treat patients with aggressive pituitary tumors, who are resistant to conventional treatments (i.e. surgery and radiation), with chemotherapy. With my colleagues at MSK, I have published several research articles on pituitary tumors and opened several clinical trials.